체외 진단 시장 : 규모, 점유율, 성장 분석, 제품별, 기술별, 검체별, 검사 유형별, 용도별, 최종 사용자별, 지역별 산업 예측(2024-2031년)

Global In-Vitro Diagnostics Market size was valued at USD 83.50 Billion in 2022 and is poised to grow from USD 87.93 Billion in 2023 to USD 132.90 Billion by 2031, growing at a CAGR of 5.3% during the forecast period (2024-2031).

The in-vitro diagnostics market is poised for growth, driven by the rising prevalence of chronic diseases and an increasing consumer demand for early and precise diagnostic solutions. Investments in medical research and development, along with advancements in technologies, will further enhance the capabilities of in-vitro diagnostics firms. Additionally, an aging population, a surge in disease testing requirements, and the growing trend towards personalized medicine present substantial opportunities for market players. Nonetheless, challenges such as high development costs, stringent regulatory requirements, and limited reimbursement options may hinder long-term demand. Overall, stakeholders should navigate these dynamics to capitalize on the promising growth landscape within the in-vitro diagnostics sector through 2023 and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In-Vitro Diagnostics Market Segmental Analysis

Global In-Vitro Diagnostics Market is segmented by Product, Technology, Specimen, Test Type, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments, Data Management Software & Services. Based on Technology, the market is segmented into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Chromatography & Mass Spectrometry. Based on Specimen, the market is segmented into Blood, Serum, Plasma, Saliva, Urine. Based on Test Type, the market is segmented into Laboratory Tests, Point-Of-Care Tests. Based on Application, the market is segmented into Infectious Diseases, Oncology, Endocrinology, Cardiology, Blood Screening, Genetic Testing, Autoimmune Diseases, Autoimmune Diseases, Allergy Diagnostics, Drug Monitoring & Testing, Bone & Mineral Disorders, Coagulation Testing, Blood Group Typing, Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Blood Banks, Home Care Settings, Pharmaceutical & Biotechnology Companies, Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is significantly influenced by several key drivers. Rapid advancements in technology and the growing demand for early and accurate disease detection are paramount in propelling market growth. Additionally, the increasing prevalence of chronic and infectious diseases, along with the rise in patient awareness regarding health monitoring, further fuels the market. Government initiatives promoting healthcare access and investments in research and development also contribute to the expansion of this sector. Furthermore, the aging population, which demands advanced diagnostic solutions, is another critical factor driving the growth of the In-Vitro Diagnostics market globally.

Restraints in the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market faces several constraints that may hinder its growth. Factors such as stringent regulatory requirements, which vary significantly by region, can complicate the approval process for new diagnostic products. Furthermore, the high costs associated with research and development pose a significant barrier, particularly for smaller firms lacking substantial financial resources. Additionally, the increasing competition among established players and emerging startups can lead to market saturation, driving prices down and affecting profitability. Lastly, the ongoing challenges related to data privacy and cybersecurity in healthcare can create further obstacles for innovation and market expansion in the in-vitro diagnostics sector.

Market Trends of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is experiencing a significant trend toward home care solutions, driven by increasing consumer demand for convenience and accessibility. This shift is prompting in-vitro diagnostics companies to innovate and develop user-friendly test kits designed for at-home use, negating the need for medical supervision. As healthcare systems evolve and patients seek personalized and immediate testing options, these developments represent a lucrative opportunity for manufacturers. By capitalizing on the growing popularity of homecare, the in-vitro diagnostics sector is poised for robust revenue growth, while also improving patient engagement and outcomes on a global scale.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global In-Vitro Diagnostics Market Size by Product & CAGR (2024-2031)

• Market Overview
• Reagents & Kits
• Instruments
• Data Management Software & Services

Global In-Vitro Diagnostics Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Immunoassays
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Chemiluminescence Immunoassays
  • Immunofluorescence Assays
  • Rapid Tests
  • Enzyme-Linked Immunospot Assays (Elispot)
  • Western Blotting
  • Other
• Clinical Chemistry
  • Basic Metabolic Panels
  • Liver Panels
  • Renal Profiles
  • Lipid Profiles
  • Thyroid Function Panels
  • Electrolyte Panels
  • Specialty Chemical Tests
• Molecular Diagnostics
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • In Situ Hybridization (ISH)
  • DNA Microarrays
  • Other
• Hematology
• Microbiology
• Coagulation & Hemostasis
• Urinalysis
• Chromatography & Mass Spectrometry

Global In-Vitro Diagnostics Market Size by Specimen & CAGR (2024-2031)

• Market Overview
• Blood
• Serum
• Plasma
• Saliva
• Urine

Global In-Vitro Diagnostics Market Size by Test Type & CAGR (2024-2031)

• Market Overview
• Laboratory Tests
• Point-Of-Care Tests

Global In-Vitro Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Infectious Diseases
• Oncology
• Endocrinology
• Cardiology
• Blood Screening
• Genetic Testing
• Autoimmune Diseases
• Autoimmune Diseases
• Allergy Diagnostics
• Drug Monitoring & Testing
• Bone & Mineral Disorders
• Coagulation Testing
• Blood Group Typing
• Other Applications

Global In-Vitro Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Blood Banks
• Home Care Settings
• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Other End Users

Global In-Vitro Diagnostics Market Size & CAGR (2024-2031)

• North America, (Product, Technology, Specimen, Test Type, Application, End User)
  • US
  • Canada
• Europe, (Product, Technology, Specimen, Test Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Technology, Specimen, Test Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Technology, Specimen, Test Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Technology, Specimen, Test Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transasia Bio-Medicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Voxtur Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peerless Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation